Search results for: “biopharmaceutical”
-
Arecor Therapeutics granted key patents in Europe and China
•
CAMBRIDGE, UK: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, announced…
-
Imagion Biosystems appoints Dr. Isaac Bright as CEO to drive next phase of growth
•
Melbourne, Australia: Imagion Biosystems (ASX: IBX), a leading healthcare company focused on early cancer detection, is thrilled to…
-
Psych Capital acquires Shortwave Pharma to expand eating disorder treatment portfolio
•
LONDON, UK: Psych Capital PLC, a leading global investment firm specializing in the healthcare sector, has announced that…
-
Biologics Manufacturing Trends: Insights from Leading CDMOs
•
Biologics, a class of pharmaceutical products derived from living organisms, have revolutionized the field of medicine, offering highly…
-
Kazia Therapeutics CEO Dr James Garner Resigns, Dr John Friend Assumes Role
•
SYDNEY, AUSTRALIA: Kazia Therapeutics Limited , an oncology-focused drug development company, today announced that Chief Executive Officer and…
-
GSK to acquire Canada-based BELLUS Health for $2 billion
•
LONDON, UK: GSK plc and BELLUS Health Inc. have entered into a deal in which GSK will acquire…
-
Sartorius Stedim Biotech agrees to acquire Polyplus for 2.4 billion euros
•
PARIS, FRANCE: Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to…
-
Dotz Nano Limited appoints Sharon Malka as Chief Executive Officer
•
SYDNEY, AUSTRALIA: Dotz Nano Limited (ASX:DTZ) announced Mr Sharon Malka has been appointed Chief Executive Officer of the…
-
WPP acquires 3K Agentur für Kommunikation, a German PR agency
•
LONDON, UK: WPP Plc has acquired 3K Agentur für Kommunikation (3K), one of the leading healthcare specialist PR…
-
Stephen Turner appointed CEO of Nutritional Growth Solutions
•
SYDNEY, AUSTRALIA: Nutritional Growth Solutions (ASX: NGS) announced a strategic leadership restructure to focus on the growth of…
-
Cann Group appoints Peter Koetsier as new CEO
•
SYDNEY, AUSTRALIA: Cann Group Limited (ASX: CAN) announced that Peter Koetsier has been appointed to the role of…
-
AstraZeneca agrees to acquire CinCor Pharma for upto $1.8 billion
•
LONDON, UK: AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma Inc., a US-based clinical-stage biopharmaceutical…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.